| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,769 |
19,059 |
$885K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,992 |
5,588 |
$369K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,091 |
6,304 |
$171K |
| 99401 |
|
8,237 |
7,263 |
$144K |
| 94010 |
|
4,586 |
4,577 |
$94K |
| 99497 |
|
1,745 |
1,737 |
$79K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,487 |
3,269 |
$78K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,389 |
1,385 |
$77K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,088 |
1,086 |
$73K |
| 93000 |
|
5,768 |
5,712 |
$71K |
| 92557 |
|
3,330 |
3,326 |
$69K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,325 |
1,320 |
$67K |
| 99385 |
|
827 |
827 |
$55K |
| 83970 |
|
2,647 |
2,626 |
$53K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
264 |
264 |
$45K |
| 92587 |
|
2,140 |
2,134 |
$44K |
| 92570 |
|
2,607 |
2,603 |
$41K |
| 82670 |
|
2,969 |
2,945 |
$38K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
562 |
562 |
$38K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,056 |
3,021 |
$37K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
4,705 |
3,914 |
$35K |
| 82627 |
|
2,874 |
2,853 |
$30K |
| 82607 |
|
4,350 |
4,308 |
$29K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
702 |
651 |
$28K |
| 82728 |
|
4,237 |
4,197 |
$28K |
| 82746 |
|
4,241 |
4,202 |
$28K |
| 86141 |
|
4,601 |
4,543 |
$26K |
| 86769 |
|
1,118 |
1,108 |
$25K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,729 |
4,681 |
$24K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
953 |
950 |
$23K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
457 |
428 |
$21K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
373 |
360 |
$21K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
3,845 |
3,684 |
$21K |
| 80061 |
Lipid panel |
4,603 |
4,545 |
$21K |
| 80050 |
General health panel |
1,574 |
1,547 |
$20K |
| 84480 |
|
4,447 |
4,402 |
$20K |
| 84439 |
|
4,451 |
4,406 |
$20K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,347 |
2,150 |
$17K |
| 80053 |
Comprehensive metabolic panel |
2,811 |
2,764 |
$16K |
| 84144 |
|
1,592 |
1,582 |
$15K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,519 |
2,494 |
$15K |
| 83002 |
|
1,919 |
1,905 |
$15K |
| 83001 |
|
1,923 |
1,909 |
$15K |
| 84403 |
|
1,195 |
1,185 |
$15K |
| 84146 |
|
1,525 |
1,518 |
$14K |
| 83550 |
|
4,273 |
4,234 |
$14K |
| 83735 |
|
4,804 |
4,728 |
$13K |
| 83540 |
|
4,279 |
4,240 |
$12K |
| 99386 |
|
116 |
116 |
$11K |
| 84100 |
|
4,833 |
4,757 |
$11K |
| 84550 |
|
4,819 |
4,742 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
298 |
294 |
$9K |
| 3074F |
|
6,530 |
5,579 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,752 |
2,701 |
$7K |
| 81002 |
|
9,718 |
8,763 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
894 |
598 |
$7K |
| 82785 |
|
954 |
951 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
10,747 |
10,296 |
$6K |
| 83721 |
|
4,195 |
4,121 |
$6K |
| 99406 |
|
599 |
547 |
$6K |
| 99408 |
|
895 |
818 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
547 |
534 |
$5K |
| 3078F |
|
5,200 |
4,527 |
$5K |
| 94060 |
|
142 |
141 |
$5K |
| 80074 |
|
350 |
347 |
$5K |
| 86328 |
|
275 |
258 |
$5K |
| 84153 |
|
579 |
577 |
$5K |
| 84270 |
|
1,135 |
1,127 |
$4K |
| 90674 |
|
210 |
209 |
$4K |
| 3079F |
|
3,334 |
3,016 |
$3K |
| 96127 |
|
2,078 |
2,047 |
$3K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
78 |
70 |
$2K |
| 82977 |
|
592 |
584 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
175 |
171 |
$2K |
| 83615 |
|
601 |
593 |
$2K |
| 90756 |
|
107 |
106 |
$2K |
| 3075F |
|
1,580 |
1,469 |
$2K |
| 81005 |
|
2,105 |
2,053 |
$2K |
| 99173 |
|
2,197 |
2,193 |
$1K |
| 82784 |
|
360 |
352 |
$958.28 |
| 3077F |
|
1,099 |
966 |
$876.50 |
| 3080F |
|
748 |
684 |
$740.95 |
| 99201 |
|
22 |
22 |
$543.53 |
| 82948 |
|
385 |
353 |
$521.24 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
98 |
98 |
$469.96 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
78 |
70 |
$425.00 |
| 0001A |
|
17 |
17 |
$420.15 |
| 87640 |
|
17 |
16 |
$344.93 |
| 87500 |
|
31 |
28 |
$344.93 |
| 87653 |
|
30 |
28 |
$344.93 |
| 87641 |
|
31 |
28 |
$344.93 |
| 81000 |
|
207 |
183 |
$327.44 |
| 82247 |
|
2,847 |
2,791 |
$301.16 |
| 3008F |
|
5,201 |
4,291 |
$189.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
7,658 |
6,338 |
$185.50 |
| 86160 |
|
75 |
72 |
$162.58 |
| 1159F |
|
3,230 |
2,767 |
$135.50 |
| 1160F |
|
3,111 |
2,674 |
$125.50 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
82 |
54 |
$105.95 |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
63 |
56 |
$103.75 |
| 3044F |
|
621 |
593 |
$89.99 |
| G0443 |
Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes |
34 |
34 |
$88.26 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
16 |
13 |
$87.00 |
| 82248 |
|
21 |
21 |
$82.09 |
| 1036F |
|
3,217 |
2,718 |
$70.00 |
| 99051 |
|
30 |
30 |
$68.43 |
| 87486 |
|
12 |
12 |
$60.33 |
| 87581 |
|
12 |
12 |
$60.33 |
| 4004F |
|
393 |
353 |
$42.00 |
| 2023F |
|
21 |
21 |
$3.50 |
| 1111F |
|
16 |
14 |
$0.00 |
| 1000F |
|
94 |
85 |
$0.00 |
| 1125F |
|
205 |
180 |
$0.00 |
| 3011F |
|
299 |
272 |
$0.00 |
| 99050 |
|
38 |
37 |
$0.00 |
| 87498 |
|
14 |
12 |
$0.00 |
| G8430 |
Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an acute health crisis where time is of the essence and delay of treatment would jeopardize the patient's health status) |
372 |
350 |
$0.00 |
| 99070 |
|
48 |
48 |
$0.00 |
| 1126F |
|
434 |
371 |
$0.00 |
| 3048F |
|
96 |
84 |
$0.00 |
| G8428 |
Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given |
136 |
124 |
$0.00 |
| 3049F |
|
78 |
71 |
$0.00 |
| 99000 |
|
79 |
77 |
$0.00 |
| 3725F |
|
307 |
305 |
$0.00 |
| 3288F |
|
137 |
124 |
$0.00 |
| 4013F |
|
19 |
18 |
$0.00 |